Of note, a subgroup analysis of our cohort showed that the prognostic value of MGMT promotor methylation was only retained in IDHwt astrocytomas, but not in IDH-mutant glioma with or without 1p19q co-deletion. The gene discussed is MGMT; the disease is central nervous system cancer.